Hydroxyurea, a well-established inhibitor of RRM2, inhibited the growth of Ewing sarcoma cells at concentrations (IC50 range 165-300 μM) that are significantly lower than concentrations typically used for cell cycle synchronization (> 1 mM) (Figure 3E) [35]. Here, RRM2 is linked to Ewing sarcoma.